ArticleScientific reports2025
Inflammation, toxicity, and apoptosis reducing potential of bacteriophage Ariobarzanes on intestinal cells infected with Salmonella Typhimurium.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Phenotypic characterization of raw milk-associated Pseudomonas spp.: biofilm formation across different temperatures, antimicrobial resistance, and cytotoxicity.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Prophage: agent provocateur?Archives of microbiology · 2026Review
- Targeting PANoptosis in Bacterial-Induced Inflammatory Diseases: Mechanisms and Therapeutic Interventions.Journal of inflammation research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of antimicrobial-resistant bacteria has urged researchers to find alternatives or adjunct therapies, such as bacteriophages or phages. This study aimed to investigate the capabilities of Salmonella Typhimurium-specific phage Ariobarzanes in reducing cytotoxicity, invasion, and induction of necrosis and apoptosis caused by Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) ATCC 14,028 infection in the human small intestinal cell line Caco-2. For this purpose, cytotoxicity tests were performed, and the production of inflammatory cytokines interleukin-8 (IL-8) and tumor necrosis factor -alpha (TNF-α) was investigated in phage-treated versus non-treated samples (for 6-hour or 16-hour). The results indicate the success of Ariobarzanes in reducing cytotoxicity in a dose dependently, completely inhibiting Salmonella spp. invasion of Caco-2 cells, reducing Salmonella-induced apoptosis, and necrosis, and also reducing the production and secretion of cytokines IL-8, and TNF-α compared to the bacterial control treatment. Therefore, Ariobarzanes can be introduced as a potential candidate for controlling S. Typhimurium in the agriculture, food, and/or pharmaceutical industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.